Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer
Status:
Terminated
Trial end date:
2021-05-14
Target enrollment:
Participant gender:
Summary
This study is a prospective, multi-center, open-label phase I trial designed to determine the
maximun tolerated dose of IP oxaliplatin when given in combination with mFOLFIRI.